A diverse range of gene products are effectors of the type I interferon antiviral response

被引：0
|
作者：
John W. Schoggins
Sam J. Wilson
Maryline Panis
Mary Y. Murphy
Christopher T. Jones
Paul Bieniasz
Charles M. Rice
机构：
[1] Laboratory of Virology and Infectious Disease,
[2] Center for the Study of Hepatitis C,undefined
[3] The Rockefeller University,undefined
[4] Howard Hughes Medical Institute,undefined
[5] Laboratory of Retrovirology,undefined
[6] Aaron Diamond AIDS Research Center,undefined
[7] The Rockefeller University,undefined
来源：
Nature | 2011年 / 472卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
There is growing interest in antiviral interferon-stimulated genes (ISGs), such as IFITM3 and BST2 (also known as tetherin), because of their potential as drug targets. An overexpression screen has been used to assess the impact of several hundred ISGs on the replication of a number of viruses, including HIV-1 and hepatitis C virus. Combinations of validated antiviral ISGs were found to have additive effects and to converge on translational inhibition. Surprisingly, some ISGs actually enhance the replication of certain viruses, underlining the complexity of the response to interferon.
引用
收藏
页码：481 / 485
页数：4
相关论文
共 50 条
  • [1] A diverse range of gene products are effectors of the type I interferon antiviral response
    Schoggins, John W.
    Wilson, Sam J.
    Panis, Maryline
    Murphy, Mary Y.
    Jones, Christopher T.
    Bieniasz, Paul
    Rice, Charles M.
    NATURE, 2011, 472 (7344) : 481 - U545
  • [2] Correction: Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response
    John W. Schoggins
    Sam J. Wilson
    Maryline Panis
    Mary Y. Murphy
    Christopher T. Jones
    Paul Bieniasz
    Charles M. Rice
    Nature, 2015, 525 : 144 - 144
  • [3] A diverse range of gene products are effectors of the type I interferon antiviral response (vol 472, pg 481, 2011)
    Schoggins, John W.
    Wilson, Sam J.
    Panis, Maryline
    Murphy, Mary Y.
    Jones, Christopher T.
    Bieniasz, Paul
    Rice, Charles M.
    NATURE, 2015, 525 (7567) : 144 - 144
  • [4] New developments in the induction and antiviral effectors of type I interferon
    Liu, Su-Yang
    Sanchez, David Jesse
    Cheng, Genhong
    CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (01) : 57 - 64
  • [5] LncRNAs in the Type I Interferon Antiviral Response
    Suarez, Beatriz
    Prats-Mari, Laura
    Unfried, Juan P.
    Fortes, Puri
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 34
  • [6] Unraveling the complexity of the type I interferon antiviral response
    Schoggins, John W.
    Wilson, Sam J.
    Panis, Maryline
    Murphy, Mary Y.
    Jones, Christopher T.
    Bieniasz, Paul
    Rice, Charles M.
    CYTOKINE, 2011, 56 (01) : 48 - 48
  • [7] Mechanisms of Evasion of the Type I Interferon Antiviral Response by Flaviviruses
    Diamond, Michael S.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (09): : 521 - 530
  • [8] Inhibition of the Type I Interferon Antiviral Response During Arenavirus Infection
    Borrow, Persephone
    Martinez-Sobrido, Luis
    de la Torre, Juan Carlos
    VIRUSES-BASEL, 2010, 2 (11): : 2443 - 2480
  • [9] The diverse roles of type I interferon in response to EMCV and SeV infections
    Bedsaul, Jacquelyn
    Zaritsky, Luna
    Zoon, Kathryn
    CYTOKINE, 2015, 76 (01) : 69 - 69
  • [10] The Type I interferon antiviral gene program is impaired by lockdown and preserved by caregiving
    Cole, Steven W.
    Cacioppo, John T.
    Cacioppo, Stephanie
    Bone, Kyle
    Del Rosso, Laura A.
    Spinner, Abigail
    Arevalo, Jesusa M. G.
    Dizon, Thomas P.
    Capitanio, John P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (29)
12345